logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Adam D. Cohen

Abramson Cancer Center
H指数:63
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

作者更正：FcRH5×CD3 双特异性抗体 cevostamab 在复发或难治性多发性骨髓瘤中的研究：一项1期临床试验

Nature Medicine
IF50
2026-10-200
OAAI
Adam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

FcRH5×CD3双特异性抗体塞沃司单抗在复发或难治性多发性骨髓瘤中的应用：一项I期临床试验

Nature Medicine
IF50
2026-07-220
OAAI
Adam D. Cohen; Joshua Richter; Suzanne Trudel; Alexander Lesokhin; Jacob P. Laubach; Sheeba K. Thomas; Simon J. Harrison; Luciano J. Costa; Andrew Spencer; Rafael Fonseca; Peter A. Forsberg; Jesus G. Berdeja; Rayan Kaedbey; Nizar J. Bahlis; Paula Rodriguez-Otero; Maria-Victoria Mateos; Tulika Tyagi; Divya Samineni; Wenyu Liu; Rin Nakamura; Voleak Choeurng; Chihunt Wong; James Cooper; Amrita Krishnan
Investigating Associations Between Psychological Distress and Changes in Peripheral Blood Monocytes in Patients With CLL/SLL Managed With Active Surveillance

探究心理困扰与接受主动监测的CLL/SLL患者外周血单核细胞变化之间的关联

Cancer Medicine
IF3.1
2026-05-150
OAAI
Carolyn Y. Fang; Alexander W. MacFarlane IV; Henry C. H. Fung; Nadia Khan; Stefan K. Barta; Jill S. Hasler; Hatcher J. Ballard; Daniel J. Landsburg; Sunita D. Nasta; Stephen J. Schuster; Rashmi Khanal; Richard I. Fisher; Adam D. Cohen; Jakub Svoboda; Kerry S. Campbell
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy

CD4 T细胞介导BCMA car-t细胞治疗后car-t细胞相关的免疫相关不良事件

Nature Medicine
IF50
2026-01-150
PRE
Matthew Ho; Luca Paruzzo; Julia Han Noll; Federico Stella; Pooja Devi; Sonia Ndeupen; Yael A. Day; Gregory M. Chen; Ivan J. Cohen; Angel Ramirez-Fernandez; Adam Waxman; Shivani Kapur; Fang Chen; Rong Xu; Andrew Huff; Danuta Jarocha; Vrutti Patel; Audrey C. Bochi-Layec; Ranjani Ramasubramanian; Shan Liu; Riemke Bouvier; Vitor B. de Souza; Heta Patel; Ziyu Li; Alberto Carturan; Peter Michener; Caitlin R. Hopkins; Owen Koucky; Janna Minehart; Alex Dimitri; Neel R. Nabar; Zainul S. Hasanali; Bryan T. Ciccarelli; Putzer Hung; Erik Williams; Robert Bartoszek; Maya Lavorando; Suyash Mohan; Vanessa E. Gonzalez; Patrizia Porazzi; Vijay G. Bhoj; Sokratis A. Apostolidis; Dan T. Vogl; David L. Porter; John Scholler; Caroline Diorio; Aoife M. Roche; John K. Everett; Frederic D. Bushman; Katherine L. Nathanson; Edward A. Stadtmauer; Sandra P. Susanibar-Adaniya; Alfred L. Garfall; Marco Ruella; Adam D. Cohen; Joseph A. Fraietta
Outcomes of relapse after teclistamab therapy in multiple myeloma

接受特昔利珠单抗治疗后多发性骨髓瘤复发的结局

Blood Cancer Journal
IF11.6
2025-11-050
OAAI
Kyle L. Yu; Matthew Ho; Luca Paruzzo; Federico Stella; Heta Patel; Zainul S. Hasanali; Shivani Kapur; Adam J. Waxman; Dan T. Vogl; Edward A. Stadtmauer; Joseph A. Fraietta; Marco Ruella; Adam D. Cohen; Alfred L. Garfall; Sandra Susanibar-Adaniya
Trial in Progress (TiP): Interim analysis of a Phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with Vitamin K in combination with Standard of Care (SOC) RT and TMZ in Glioblastoma Multiforme (GBM) patients without prior therapy

进行中试验（TiP）：一项关于BPM31510（氧化辅酶Q10的脂质纳米分散体）联合维生素K，与标准护理（SOC）放疗（RT）和替莫唑胺（TMZ）联用治疗未经前期治疗的胶质母细胞瘤（GBM）患者的II期研究的期中分析

NEURO-ONCOLOGY
IF13.4
2025-11-010
OAAI
Nagpal, Seema; Stockdale, Brian; Cohen, Adam; Patil, Chirag; Vaillant, Brian; Elmore, Kevin; Brenner, Andrew; Juthani, Rupa; Reardon, David; Kendle, Ryan; Spira, Alexander; Wykretowicz, Jedrzej; Zhukova-Harrill, Valentina; Nie, Bing; Narain, Niven; Modur, Vijay
Efficacy and Safety of Anti-CDI9 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-Cell Therapies in Patients with Autoimmune Disease and Lymphoma or Myeloma

抗CDI9和抗BCMA嵌合抗原受体（CAR）T细胞疗法在自身免疫性疾病、淋巴瘤或骨髓瘤患者中的疗效与安全性

BLOOD
IF23.1
2024-11-050
PRE
Paruzzo, Luca; Bouvier, Riemke; Ghilardi, Guido; Fardella, Eugenio; Fulmer, Bria; Cohen, Ivan J.; Chong, Elise A.; Svoboda, Jakub; Nasta, Sunita D.; Landsburg, Daniel J.; Patel, Vrutti; Ziyu, Li; Pajarillo, Raymone; Waxman, Adam; Cohen, Adam D.; Vogl, Dan T.; Barta, Stefan K.; Porazzi, Patrizia; Fraietta, Joseph A.; Bhoj, Vijay; Garfall, Alfred L.; Stadtmauer, Edward A.; Schuster, Stephen J.; Carter, Jordan S.; Apostolidis, Sokratis A.; Susanibar-Adaniya, Sandra; Ruella, Marco
Tasquinimod, an S100A9 Inhibitor, in Combination with Ixazomib, Lenalidomide, and Dexamethasone for Relapsed and Refractory Multiple Myeloma

Tasquinimod，一种S100A9抑制剂，与伊沙佐米、来那度胺和地塞米松联合用于复发性和难治性多发性骨髓瘤。

BLOOD
IF23.1
2024-11-050
PRE
Vogl, Dan T.; Nefedova, Yulia; Wileyto, E. Paul; Nguyen, Chau; Diaczynsky, Cynthia; Strakovsky, Inna; Bondesson, Eva; Tuvesson, Helen; Vahtola, Erik; Cohen, Adam D.; Susanibar-Adaniya, Sandra; Waxman, Adam; Kapur, Shivani; Garfall, Alfred L.; Stadtmauer, Edward A.
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

商业CAR T细胞治疗后T细胞淋巴瘤和继发性原发性恶性肿瘤风险

NATURE MEDICINE
IF50
2024-01-2481
PRE
Ghilardi, Guido; Fraietta, Joseph A.; Gerson, James N.; Van Deerlin, Vivianna M.; Morrissette, Jennifer J. D.; Caponetti, Gabriel C.; Paruzzo, Luca; Harris, Jaryse C.; Chong, Elise A.; Adaniya, Sandra P. Susanibar; Svoboda, Jakub; Nasta, Sunita D.; Ugwuanyi, Ositadimma H.; Landsburg, Daniel J.; Fardella, Eugenio; Waxman, Adam J.; Chong, Emeline R.; Patel, Vrutti; Pajarillo, Raymone; Kulikovskaya, Irina; Lieberman, David B.; Cohen, Adam D.; Levine, Bruce L.; Stadtmauer, Edward A.; Frey, Noelle V.; Vogl, Dan T.; Hexner, Elizabeth O.; Barta, Stefan K.; Porter, David L.; Garfall, Alfred L.; Schuster, Stephen J.; June, Carl H.; Ruella, Marco
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study
LANCET HAEMATOLOGY
IF17.7
2022-12-0121
PRE
Martin, Thomas; Lin, Yi; Agha, Mounzer; Cohen, Adam D.; Htut, Myo; Stewart, A. Keith; Hari, Parameswaran; Berdeja, Jesus G.; Usmani, Saad Z.; Yeh, Tzu-Min; Olyslager, Yunsi; Goldberg, Jenna D.; Schecter, Jordan M.; Madduri, Deepu; Jackson, Carolyn C.; Deraedt, William; Gries, Katharine S.; Fastenau, John M.; Trudeau, Jeremiah J.; Akram, Muhammad; Pacaud, Lida; Jakubowiak, Andrzej; Jagannath, Sundar

研究方向

暂未获取到该数据
A
Alfred L. Garfall
H 指数:41论文数:312被引数:1.1万
D
Dan T. Vogl
H 指数:50论文数:358被引数:1.7万
E
Edward A. Stadtmauer
H 指数:88论文数:628被引数:3.6万
S
Sandra P. Susanibar-Adaniya
H 指数:10论文数:121被引数:1,035
A
Adam Waxman
H 指数:18论文数:80被引数:2,576
C
Carl H. June
H 指数:177论文数:1,428被引数:14.4万
S
Simon F. Lacey
H 指数:75论文数:382被引数:3.8万
B
Bruce L. Levine
H 指数:102论文数:550被引数:6.6万
J
Joseph A. Fraietta
H 指数:45论文数:359被引数:1.5万
S
Sundar Jagannath
H 指数:109论文数:1,101被引数:6.2万